Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Wedding gifts: Fiercely determined for marriage

NOMOS Glashütte now has the ideal watches to celebrate a wedding. Our new Tetras are square, in all shades of pink—and made with love. Their names: Die Kapriziöse, Die Wildentschlossene, Die Fuchsteufelswilde and Die Unerreichbare. There you have it!GLASHÜTTE IN MAY 2023. What makes the perfect gift for bride or groom? It should, of course, be like the love of their life: dependable, beautiful, smart and for ever—a perfect companion. It should remind them of their big day and only grow in value over the years. NOMOS Glashütte, located in the famous watchmaking town of Glashütte, has

Cloudberry Clean Energy ASA | Odin Transaction Closed

Oslo, Norway, 31 May 2023: 10[th] of February 2023 Cloudberry Clean Energy ASA (“Cloudberry” or the “Company”) announced to the stock exchange the signing of a sale and share purchase agreement (“Transaction”) with Skovgaard Energy A/S (“Skovgaard”) for 80% of the share in Odin Energy Holding P/S (“Odin”).Today Cloudberry announces the completion of the Transaction, adding a total of 106 MW net to Cloudberry primarily in the favorable DK1 price region. All assets in the previously announced Tranche 2 were included in the Transaction.   The final purchase price for 80% of the shares in

EQL Pharma out-licenses Methenamine Hippurate to Dr. Pfleger Arzneimittel for the German market

EQL has entered into an exclusive license agreement for the German market for EQL’s product Methenamine Hippurate with Dr. Pfleger Arzneimittel, a leading German company in urology and gynaecology.Methenamine Hippurate is a medicine indicated for the prophylaxis of recurrent urinary tract infection (rUTI). Methenamine hippurate was launched by EQL in Sweden in 2019, in the UK (via partner) in 2020 and in Norway in 2021. EQL's ambition is to offer Methenamine to all other interesting markets in Europe via out-licensing. Methenamine hippurate is the only substance that is non-inferior to

BioStock: BrainCool’s CEO on the agreement with ZOLL

BrainCool has entered into a distribution agreement with US-based ZOLL, one of the world’s largest manufacturers and distributors of medical devices. The agreement covers the company’s IQool System for the treatment of neurological fever. BrainCool’s CEO Martin Waleij visited BioStock’s studio to talk about the deal, worth more than SEK 100 million.Watch Martin Waleij present BrainCool and talk about the agreement with ZOLL att biostock.se: https://www.biostock.se/en/2023/05/braincools-ceo-on-the-agreement-with-zoll/ This is a press release from BioStock - Connecting Innovation &

Wicket Gaming launches King Royale : Idle Tycoon - Hero LootPacks on LootBoy community platform

Starting May 31, 2023, Wicket Gaming's free-to-play game King Royale : Idle Tycoon, will offer a special pack for users on LootBoy's gaming community platform.Wicket Gaming's free-to-play game King Royale : Idle Tycoon, will be offered as a special so-called Hero Loot Pack on the LootBoy app. LootBoy is a gaming community platform that offers exclusive game-related packs (in-game offers) from the best titles on PC, console and mobile. Players can redeem in-game items via Loot Packs. LootBoy has 200,000 daily visitors and nearly 2,000,000 monthly active users, and approximately 10,000,000

Dentalum Operations AB (publ) publishes the first quarter report 2023

First quarter (January - March 2023)· Reported net revenue in the first quarter reached SEK 119.2 million (84.4). · The increase in quarterly revenue compared to the same quarter prior year, was mainly driven by acquisitions of eleven dental clinics, acquired since the same quarter 2022, of which one was completed in the first quarter of, 2023. · Consolidated EBITDA, adj. for IFRS adjustments of 4.5 million, reached SEK 22.4 million (21.1) of which SEK 28.0 million (26.7) was generated in the dental clinics and SEK -10.1 million (-5.6) of net expenses in the Parent company, Dentalum

NRC Group ASA - Appointed to a contract in Finland - EUR 26,6 million

Finnish Transport Infrastructure Agency (FTIA) has appointed NRC Group Finland, a company wholly owned by NRC Group ASA, to a contract for track, electro and groundworks at Turku railway yard. The contract is valued at approximately EUR 26,6 million. The work will commence in June 2023, and is scheduled for completion in December 2025. Closing date for submission of complaints is 14 days from today, and formal contractual signing can take place after this period at the earliest. For further information, please contact: Henning Olsen, CEO of NRC Group, + 47 91 74 15 92. This

Wicket Gamings CFO leaves the company

Jan Grigo, who has been Wicket Gaming's CFO since 2021, is leaving the company as CFO. A process to recruit a replacement has been initiated.Jan Grigo is leaving the company to take on new challenges. He will remain in his role until the end of June and the company will begin the recruitment of a replacement. "It has been an incredibly fun and exciting time at Wicket Gaming. It has been a difficult decision to make as I have enjoyed it and am many experiences richer, but lately the thoughts of taking on a new challenge have emerged in me. I remain at the company's disposal until the end

The joint venture between Swedish real estate company Europi Property Group, the Arié Family Office and Kefren Capital Real Estate has acquired its second office building in Barcelona.

The JV has recently completed the acquisition of its second office building in Barcelona, located at Carrer Lluís Muntadas 5, Cornellà. The building has been acquired from Siemens in a partial sale and leaseback transaction. The 13,088 square meter, grade A, multi-tenanted office asset is strategically located, close to local, national, and international transport infrastructure as well as nearby amenities. At acquisition, the building has an occupancy ratio of 86% and is partially occupied by Siemens group companies as well as other blue-chip tenants such as Nexeo Solutions, ISS, TDK, and

Audientes: focused strategy and initial funding in place

Company Announcement 18-2023May 31, 2023 Audientes A/S (CVR 36047631) today announces that it has secured a new convertible loan of DKK 750,000 from existing lenders as part of its strategy focused largely on the Indian market.Focused strategy: Audientes has formulated and have begun to execute on a highly focused strategy with its new exclusive partner Earkart in India as focal point. This translates to an opportunity to reach break-even in operations with total financing of less than DKK 5 million due to a cost-optimized operational approach. With this, Audientes will be fully

Notice of delisting

The bankruptcy estate of DOF ASA has been notified by Oslo Børs that Oslo Børs intends to delist DOF ASA from Oslo Børs due to the fact that bankruptcy proceedings have been opened in DOF ASA and the company no longer satisfy the conditions for listing. As previously informed, all of the subsidiaries in the DOF group have been acquired by DOF Group ASA, which is the new holding company in the group. The business of the DOF group is thus not affected by the bankruptcy in DOF ASA nor will it be affected by a delisting of DOF ASA from Oslo Børs.

Hamlet Pharma secures a new Alpha1H production batch for continued clinical trials

Lund, May 31, Hamlet Pharma soon to be Hamlet BioPharma, the innovative pharmaceutical company with a strong portfolio of projects for the treatment of cancer and infections,  announces that Hamlet Pharma has secured the production of larger quantities of Alpha1H. The new batch will be essential to extend the clinical trial program in patients with bladder cancer.Hamlet Pharma is manufacturing the drug candidate Alpha1H for clinical trials in collaboration with Rechon Life Science AB. The production of a new batch has now been completed according to GMP (Good Manufacturing Practice)

Strand Kapitalförvaltning selects Sharpfin for a full coverage wealth management solution

Sharpfin continues to gain market shares by delivering their Wealth Management Suite to Strand Kapitalförvaltning (Strand), a leading Swedish independent Wealth Manager.Sharpfin provides Strand Kapitalförvaltning with a solution to support all aspects of their wealth management process. This includes an efficient module for client onboarding with automatic monitoring of PEP and AML and a powerful portfolio and order management solution with model portfolios and rebalancing. In addition to this, the solution also features a fee management module which calculates management fees down to daily

Amendment of yearly coupon for NORDEN bonds issued 28 june 2021

ANNOUNCEMENT NO. 110 - 31 MAY 2023  Not for release, publication or distribution, directly or indirectly, in any jurisdiction in which such release, publication or distribution would be unlawful At 1 July 2023 the coupon on senior unsecured bonds issued 28 June 2021 (announcement no. 70/21) will change from LIBOR + 4.75% to SOFR +5.01161%.   Listing prospectus of 14 October 2021 is attached to this company announcement together with Amendment Agreement at 1 July 2023. Both documents are also available from www.norden.com.   The securities offered by Dampskibsselskabet

Change in number of shares and votes in Ependion AB

As per May 31, 2023, the total number of shares in Ependion AB amounts to 29,241,296, divided into 28,941,216 ordinary shares and 300,080 class C shares, corresponding to a total of 28,971,224 votes.The change in number of shares and votes is due to the conversion of 103,789 class C shares, which previously have been issued and repurchased within the context of the company’s incentive program LTI 2020/2023, into ordinary shares during the month of May. The number of ordinary shares has thus increased by 103,789 shares and the number of class C shares has decreased by as many shares.

Cereno Scientific publishes an additional document in conjunction with admission to trading on Nasdaq First North Growth Market

Cereno Scientific AB ("Cereno Scientific" or the "Company") publishes an additional document (the “Document”) in conjunction with the first day of trading on Nasdaq First North Growth Market ("Nasdaq First North"), which is scheduled for June 14, 2023. The Document supplements, in accordance with Nasdaq First North’s rulebook, the prospectus published by Cereno Scientific on May 5, 2023 (the “Prospectus”).The Document is to be read as a supplement to the Prospectus that the Company disclosed in connection with the recently completed rights issue which ended on May 24, 2023. The Document

P CAPITAL ANNOUNCES NAV OF P CAPITAL PARTNERS IV

Press release Stockholm, 31 May 2023 Since P Capital Partners IV AB decreased its contributed capital by EUR 10 million through a repayment to debenture holders and owners, the Net Asset Value of the P Capital Partners IV AB participation loan has been calculated. The Net Asset Value is to be calculated at the close of each quarter and in conjunction with a capital increase or decrease. The repayment amounted to EUR 3.00 per Series A participation loan debenture and EUR 0.036 million to the owners.   At the close of business on 30 May 2023, the Net Asset Value of the P

SyntheticMR Receives Regulatory Approval for their Innovative SyMRI Software Solution in South Korea

SyntheticMR announced today that their quantitative imaging software solution SyMRI 12.1 has received regulatory approval in South Korea according to KFDA (Korea Food & Drug Administration). This means that SyMRI 12.1 now can be sold and distributed in this market.“This approval for SyMRI 12.1 creates vital opportunities for us to develop our market presence in South Korea, which is one of our focus markets. We already have an established customer base in the region” says Ulrik Harrysson, CEO at SyntheticMR. “We have also seen a growing interest for our products in the region, which is very

Share capital and number of ordinary shares in JM AB (publ)

In accordance with the resolution by the Annual General Meeting (AGM) on March 30, 2023, the share capital has been reduced for allocation of SEK 3,774,001 to unrestricted equity through the elimination of 3,774,001 own ordinary shares. The share capital of SEK 68,278,841 remains unchanged since the AGM resolved on a bonus issue, without the issue of new shares and through a transfer from unrestricted equity to share capital, at the same time as it resolved to reduce the share capital through the elimination of own ordinary shares. The share capital was thus restored to the same level as

Change in the number of shares and votes in Medivir AB (publ)

Stockholm – Medivir AB (publ) (“Medivir”) (Nasdaq Stockholm: MVIR) today announces that the number of shares and votes in Medivir has changed during May 2023 as a result of the previously announced share issue of 970,500 shares of series C and the reclassification of 105,750 shares of series C into ordinary shares, which was carried out as part of the long-term incentive program for key employees within the Medivir group adopted by the annual general meeting held on 4 May 2023. As of 31 May 2023, the total number of shares in Medivir amounts to 56,706,151 of which 55,841,401 are

A-ROSA adds e-bikes on A-ROSA SENA

Plus, complimentary e-bike hire now available on A-ROSA fleetRostock, 31 May 2023 – A-ROSA has introduced e-bikes on A-ROSA SENA for the first time, including two bikes for teenagers. The move means that e-bikes are now available across 12 ships in its fleet, covering the Danube, Rhine, Main, Moselle, Seine and Rhone/Saone. In addition, A-ROSA has also introduced complimentary e-bike hire this year. This means that in selected ports guests now have the options to take an e-bike out for a spin independently, create their own route and explore a city or town on two wheels as they wish.

Fourth cohort completed in Aptahem’s FIH study

Aptahem AB (publ), a biotech company developing treatments for patients suffering from acute inflammatory diseases such as sepsis, announces today the completion of an additional cohort in the ongoing double-blinded randomized placebo controlled clinical First in Human (FIH) study.During the course of the study, there have been signs of interesting effects on clinical markers. Therefore, before starting the next cohort, extended analyses will be performed to gain a greater understanding of Apta-1’s clinical significance. These analyses will form an important basis for the further clinical

Risk Intelligence A/S and a major Norwegian Offshore Operator sign a deal for the Risk Intelligence System and bespoke intelligence support

Risk Intelligence A/S (“Risk Intelligence” or "the Company") and a high-profile Norway based offshore operator have signed an agreement giving access to the Risk Intelligence System as well as bespoke operational intelligence support.The agreement will provide the Norwegian client with enhanced situational awareness as their operations expand to new areas, supporting renewable and traditional energy projects - via Risk Intelligence’s cloud-based tool. Risk Intelligence will also provide bespoke port security assessments, area threat assessments and voyage risk assessments, ensuring that the

There are no items matching the current filter
There are no more items matching the current filter
Back to top